News & Events
-
February 12, 2018
Tucson-based Critical Path Institute emerging as top drug-research organization
President and CEO Dr. Martha Brumfield was recently interviewed by the Arizona Daily Star for a profile on C-Path published February 11. Dr. Brumfield discusses C-Path’s local ties,expanding global reach, and its recent successes, as well as its groundbreaking collaborative research model. The story outlines the work of C-Path’s consortia in the areas of biomarker...... -
February 5, 2018
Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponed
Critical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Workshop (CPTR) 2018 Annual workshop originally scheduled for April 23-25, 2018. This workshop will be rescheduled later in 2018 to better align with deliverables from our programmatic efforts and alleviate some of the logistical challenges...... - October 24, 2017
-
October 9, 2017
Critical Path Innovation Meeting
On September 14, 2017, Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium and Electronic Patient-Reported Outcome (ePRO) Consortium participated in a Critical Path Innovation Meeting (CPIM) at the U.S Food and Drug Administration’s (FDA) White Oak campus in Silver Spring, MD. As stated on FDA’s website, the goals for CPIMs are “to discuss a methodology...... - May 24, 2017
